News
Conference Summary 2014 and upcoming registration for ECCD 2015
Registration for the 2015 conference will be launched on 5 February 2015. Please download the 1st announcement (PDF file, 4 MB) for further details on this year's conference, which will be held on 29–30 May 2015 in Brno, Czech Republic.
A Conference Summary 2014 (PDF file, 2.4 MB) was published, which contains the most important conclusions of the 2014 conference and also first results of the personalised invitation programme to cancer screening in the Czech Republic.
3rd EUROPEAN COLORECTAL CANCER DAYS – photogallery and presentations available online
Photos and presentations are now available at the website:
Czech project of personalised invitation to cancer screening programmes launched: report and conclusions from experts' meeting
The workshop “Cancer Screening Programmes in the Czech Republic and Importance of Personalised Invitation”, held on 5 December 2013 in the Clarion Congress Hotel Prague, was organised by the Institute of Biostatistics and Analyses at the Masaryk University in cooperation with the WHO Office in the Czech Republic, the Kolorektum.cz Initiative, and the Office of Member of the European Parliament Dr. Pavel Poc. The workshop was held under the auspices of Martin Holcát, MD, MBA (Czech Minister of Health), Alena Šteflová, PhD, MPH (Director of the WHO Office in the Czech Republic), and Dr. Pavel Poc (Member of the European Parliament).
II. EUROPEAN COLORECTAL CANCER DAYS
BRNO 2013 - PREVENTION AND SCREENING: Stakeholder Meeting
What to do in the “era of the CRC screening guidelines”? Solution is networking!
 |
 |
Pavel Poc, Member of the European Parliament
Ladislav Dušek, Masaryk University, Institute of Biostatistics and Analyses
Colorectal cancer (CRC) is still the most common newly diagnosed cancer and the second most common cause of cancer deaths in Europe. More than 200,000 Europeans die every year from malignant tumours of the colon and rectum. However, many of these deaths can be avoided. Effective and safe colorectal cancer prevention and early detection are the key factors which can reduce both incidence and mortality of the disease. CRC screening should be accepted as one of the most desirable forms of organized cancer prevention which is to be supported by modern health care systems. Methodical aspects and scientifically driven promotion of the CRC screening were the main topics of the previous conference European Colorectal Cancer Days (ECCD), held on 4-5 May 2012 in Brno, Czech Republic. Questions and statements from the attendees during public sessions, as well as final conclusions of the ECDD 2012, challenged the organizers to continue in this networking activity.
EUROPEAN COLORECTAL CANCER DAYS: BRNO 2012 - PREVENTION AND SCREENING
"Data driven prevention has the power to save lives."
Prevention – Safety – Effectiveness
Colorectal cancer is the most common newly diagnosed cancer and the second most common cause of cancer deaths in Europe. More than 200,000 Europeans die every year from malignant tumours of the colon and rectum. However, many of these deaths can be avoided. Effective and safe colorectal cancer prevention and early detection are the key factors, and these measures do work. Numerous clinical and epidemiological studies continue to bring evidence of the valuable benefit of colorectal cancer screening both for individuals and for the populations and societies. Screening with faecal occult blood test or colonoscopy can help prevent colorectal cancer and save lives.
This meeting is intended as a networking event which should help to share up-to-date knowledge and to discuss the application of the hitherto assembled findings in establishing effective systems for colorectal cancer screening and early detection. Regardless of the recent advances in many European countries, there are still many rather persistent questions and problems that need to be addressed, such as:
- Are we able to implement new modalities in CRC screening without negatively impacting compliance by the target population?
- Are all the other aspects of CRC screening taken in account in developing new strategies: safety, feasibility, cost-effectiveness?
- What is more important in enhancing screening performance and coverage, medical or managerial factors?
- When looking at the heterogeneity of CRC screening in European countries, what is the golden standard of the population-based program? – does the gold standard exist in the first place?
- Can we extrapolate data and experience between countries with different health care management?
- What is the optimum panel for performance and quality indicators in CRC screening?
- Are there verified and positive examples of effective communication with the general public?
- Who is the most powerful “image-maker” of CRC screening? Is it the politicians, the health care payers, the patient organizations, physicians, ... celebrities?
